Description
What is it SLU-PP-332?
SLU-PP-332 is an investigational small-molecule studied as a modulator of estrogen-related receptor (ERR) signaling (primarily ERRα/ERRγ). Research explores its potential to influence cellular energy metabolism, mitochondrial function, and oxidative capacity in controlled experimental models.
Format shown: 25 mg • 60 tablets (research grade)
Research Focus Areas
-
Mitochondrial biogenesis & oxidative metabolism (gene programs linked to fatty-acid oxidation and aerobic capacity)
-
Energy balance & metabolic flexibility (substrate switching between carbohydrates and lipids)
-
Endurance and performance adaptation in preclinical exercise-mimetic models
-
Body-composition research under caloric restriction or training stimuli
Potential Research Benefits
-
Enhanced fat utilization and improved endurance capacity in experimental models
-
Preservation of lean tissue under metabolic or training stress
-
Improved metabolic function (resting energy expenditure, lipid oxidation markers)
-
Cellular recovery and performance adaptation via upregulated mitochondrial pathways
Research use only. Not for human consumption or medical/diagnostic use.
Cybergen Peptides: Research Use Disclaimer
All products offered by Cybergen Peptides are intended solely for laboratory, educational, and scientific research purposes. These materials are supplied for in-vitro research only (“in glass”) and are not intended for human or animal consumption, medical use, or diagnostic applications.
Cybergen Peptides compounds are not drugs, medicines, or dietary supplements and have not been evaluated or approved by the U.S. Food and Drug Administration (FDA) or any other regulatory agency. Any form of bodily introduction or therapeutic application is strictly prohibited.
